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[ABSTRACT] 
AIM: The anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia offici-
nalis leaves against extracellular (promastigote) and intracellular (amastigote) forms of Leishmania major were evaluated in this study. 
METHOD: In the first stage, promastigote forms of L. major, were treated with different doses of the plant extracts in a 96-well tis-
sue-culture microplate and IC50 values for each extract were measured with colorimetric MTT assay. In the second stage, macrophage 
cells were infected with L. major promastigotes. Infected macrophages were treated with plant extracts. Then the macrophages were 
stained with Gimsa and the number of infected macrophages and amastigotes were counted with a light microscope. 
RESULTS: The results indicated that the plant extracts inhibited the growth of promastigotes and amastigotes of L. major. Inhibi-
tory concentrations (IC50) for promastigote assay were 108.19, 155.15, and 184.32 µg·mL1 for C. officinalis flowers, D. stramo-
nium seeds and S. officinalis, respectively. The extracts also reduced the number of amastigotes in macrophage cells from 264 for 
control group to 88, 97, and 102 for test groups. Although the anti-leishmanial activity of the extracts were not comparable with the 
standard drug, miltefosine; but they showed significant efficiency in reducing the number of amastigotes in macrophages, in com-
parison with the control group (P < 0.001). These plant extracts had lower toxicity compared with miltefosine. 
CONCLUSION: This study demonstrates the potential efficacy of the methanolic extracts of C. officinalis flowers, D. stramonium 
seeds, and S. officinalis leaves to control of cutaneous leishmaniasis. 
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Introduction 
Cutaneous leishmaniasis (CL) is the common form of a 
disease caused by an obligate intracellular protozoa called 
leishmania, and is distinguished with cutaneous lesions on the 
exposed parts of the body. Although this form of leishmani-
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asis (CL) is not lethal and is mostly self-healing, it leaves 
permanent scars, which are often the cause of serious social 
stigmas [1-2]. The infection is acquired when a person is bitten 
by an infected sand fly. When leishmania first enters the hu-
man body, it is in the promastigote form. Macrophages uptake 
promastigotes, and are then transformed into the intracellular 
form of leishmania, called the amastigote [1-2]. Leishmaniasis 
is an endemic disease in 88 countries, especially in develop-
ing countries. Ninety % of cutaneous leishmaniasis cases 
occur in Afghanistan, Algeria, Brazil, Pakistan, Peru, Saudi 
Arabia, Syria, and Iran [3]. As there is no vaccine for preven-
tion, drug treatment (pentavalent antimony, amphotericin B, 
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and miltefosine) is the only way to control leishmaniasis [4-6]. 
However, many of the chemical drugs have toxic effects on 
different organs of human body [7]. Furthermore, the devel-
opment of resistant parasites to most drugs has been reported 
[7-8]. On the other hand, leishmaniasis is a poverty-related 
disease and is associated with malnutrition, poor housing, and 
weakness of the immune system and lack of financial re-
sources [9]. Thus cheapness and accessibility are very impor-
tant factors for drug selection. Plant materials are likely to 
provide a valuable, inexpensive, and available source for 
new medicinal agents. Adverse effects of phytotherapeutic 
agents are also less common compared with chemical drugs. 
Therefore, extracts derived from plants are suggested to 
have new compounds active against leishmania. However, 
phytopharmaceuticals can be used as a drug for treatment, 
only if their effectiveness versus chemical drugs is proven 
[9]. Plant materials, such as saponins, quinones, alkaloids, 
terpenes, phenol derivatives, and some other metabolites are 
reported to have anti-parasitic and anti-leishmanial activities 
[10]. Plants were used in this study have many medicinal uses. 
Calendula officinalis L. (Asteraceae) flowers (pot marigold) 
have anti-microbial effects [11-12] on some microorganisms 
such as Escherichia coli, Pseudomonas aeruginosa, Bacillus 
subtilis, and Staphylococcus aureus; and anti-fungal effects 
against Candida albicans and Candida parapsilosis [13-14]. 
There is a report about the anti-parasitic effects of oleanolic 
acid and glycosides isolated from C. officinalis [15]. Oleano-
lic acid was also found in Salvia officinalis L. (Lamiaceae) 
and showed antimicrobial activity [16]. Furthermore, this 
plant is indicated to have some anti-fungal activities against 
Saccharomyces cerevisiae [17]. The anti-microbial and 
anti-fungal activities of D. stramonium seed extract were 
also reported [18 -19]. 
In this study, the anti-leishmanial activities of methanolic 
extracts of C. officinalis flowers, Datura stramonium L. (So-
lanaceae) seeds and S. officinalis leaves against L. major 
promastigotes, were evaluated in cell free cultures, and 
against amastigotes, in a macrophage cell line. 
Materials and Methods 
Plants materials  
    Plants were collected from Tehran province, Iran, in June 
2011. Botanical identification was performed by botanists in 
the Department of Pharmacognosy, Faculty of Pharmacy, 
Tehran University of Medical Sciences, Tehran, Iran, and 
voucher specimens were retained in the herbarium (C. offici-
nalis number: 1499, D. stramonium number: 1677, S. offici-
nalis number: 1533). 
Preparation of extracts  
The extraction process was performed using the cold 
percolation method. The C. officinalis flowers, D. stramonium 
seeds, and S. officinalis leaves were dried at room temperature, 
and then were ground with a blender. A sample (50 g) of each 
powder was macerated in 80% methanol (300 mL) for 48 h in 
room temperature with shaking. The crude extracts were ob-
tained after filtration with Whatman No. 1 filter paper, and 
were evaporated under low pressure at below 40 C in a rotor 
evaporator [20]. The extracts were dried, weighed, and finally 
dissolved in 1% DMSO with 31.25, 62.5, 125, 250, 500, and 
1 000 µg·mL1 proportions for further usage. 
Parasite  
L. major promastigotes (strain MROH/IR/75/IR, pro-
vided by the Pasteur Institute of Iran) were used for in vitro 
screening. The promastigotes were maintained in Novy- 
Macneal-Nicolle (NNN) medium, at 25 ºC. Phosphate buff-
ered saline (PBS, pH 7.2) was used as the liquid phase of the 
culture medium. 
Anti-promastigote activity assay  
L. major promastigotes were cultured in RPMI medium 
supplemented with 10% fetal calf serum overnight, to 
reach the logarithmic phase. Then, plant extracts dissolved 
in DMSO were added to a 96-well tissue-culture micro 
plate and serial dilution, with descending concentrations, 
from 1 000 to 31.25 µg·mL1, was performed. Neubauer 
chambers containing 2 × 106 promastigotes/mL were then 
added to each well (50 µL). The plate was incubated at 25 
ºC for 48 h. The viability of promastigotes was assessed by 
tetrazolium-dye (MTT) colorimetric method [21-22]. Briefly, 
MTT solution (25 µL, 0.5 mg·mL1) was added to each 
well and incubated for 3–4 h at 37 ºC. Then, DMSO (100 
µL) was added to dissolve the MTT formazan, and finally 
the optical density (OD) was measured using an ELISA 
plate reader at 570 nm. The control wells contained DMSO 
without drugs. In addition, miltefosine (Sigma, USA) was 
used as the standard drug.  
Anti-amastigote activity assay  
The macrophage J774 cells (ATCC number TIB-67) were 
supplied by the Pasteur Institute of Iran. The cells were cul-
tured in RPMI 1640, supplemented with 10% heat-inactivated 
fetal bovine serum and penicillin (100 U·mL1)-streptomycin 
(100 µg·mL1), and were maintained at 37 C in a CO2 in-
cubator. The anti-amastigote activites of the plant extracts 
were performed according to routine methods [23]. Briefly, 
the cells (4 × 105/well) were cultured in a 24-well mi-
croplate containing glass coverslips. After 4 h, non-adherent 
cells were removed and plate was incubated at 37 C and 
5% CO2 for 24 h. After incubation, macrophages were in-
fected with L. major promastigotes with a parasite/macr-
ophage ratio of 7 : 1, and after 4 h incubation, free promas-
tigotes were removed by washing with PBS. After an over-
night incubation at 37 ºC and 5% CO2, the plant extracts 
were added to the plate wells with concentrations of 1 000 
to 31.25 µg·mL1. The media containing drugs were re-
newed after 48 h. After 60 h incubation, coverslips were 
washed with PBS, fixed in methanol, stained with 10% 
Giemsa solution, and examined with a light microscope. The 
number of infected macrophages and also amastigotes, in 
100 macrophages, were counted and the results presented as 
infection rate (IR) and parasite survival (PS) [22]:  
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IR = No. of infected macrophages in 100 macrophages 
PS=
No.of amastigotes inexperimental culture/100 macrophages×100
No.of amastigotes in control culture/100 macrophages  
Cytotoxicity for macrophages  
The toxicity of extracts for macrophage cells was as-
sessed by the MTT colorimetric assay. First, the J774 
macrophage cells (2 × 105/well) were added in a 96 wells 
micro plate. After 24 h incubation at 37 ºC and 5% CO2, the 
cells were exposed to plant extracts at the same concentra-
tions that were used in the anti-amastigote assay. After 60 h 
incubation at 37 ºC, MTT (20 µL, 0.5 mg·mL1) were added 
to each well, and then the plate was re-incubated for 4 h. 
The optical density (OD) at 570 nm was measured. Cell 
viability was determined using the following formula [22]:  
Optical density in experimental wellCell viability (%) 100
Optical density in control well
   
Statistical analysis  
Data are presented as x ± s of the mean (SEM). Differ-
ences between groups were analyzed by one-way ANOVA 
followed by Tukey multiple comparison test. A P < 0.05 was 
considered to be statistically significant 
RESULTS 
Anti-promastigote assay 
Results of this study demonstrated that IC50 value for 
methanolic extracts of C. officinalis flowers, D. stramonium 
seeds, and S. officinalis leaves in the promastigote assay were 
at doses of 108.19, 155.15, and 184.32 µg·mL1, respectively 
(Table 1). Miltefosine, as a standard drug, with an IC50 value 
of 5.3 µg·mL1 showed a potent anti-leishmanial activity on 
the L. major promastigotes. The IC50 value for the miltefosine 
group was significantly less than those of the plant extracts  
(P < 0.001).  
Table 1  IC50 values for methanolic plant extracts in promastigote assay. 
Groups Family Organ Common name IC50 for promastigote assay (µg·mL1) 
C. officinalis Asteraceae Flowers Pot marigold 108.19 ± 8.6 
D. stramonium Solanaceae Seeds Jimson weed 155.15 ± 10.1 
S. officinalis Lamiaceae Leaves garden sage 184.32 ± 11.7 
Miltefosine — — — 5.3 ± 1.2** 
** P < 0.001 vs other groups 
 
L. major promastigotes treated with the C. officinalis ex-
tract had the lowest viability among the other extracts. 
Anti-amastigote assay 
Different concentrations of the plant extracts were tested 
for their activity against amastigotes in macrophage cells. In-
fection Rate (IR) values demonstrate the percentage of infected 
macrophages in samples. IR values showed a significant de-
crease in test groups compared with the control group (P < 
0.001). This decrease suggests that some macrophages were 
cleaned from amastigotes (Fig. 1). Miltefosine, with twenty 
infected macrophages after treatment, had a better 
anti-amastigote activity than other groups. IR value for C. offi-
cinalis extract, was significantly lower than that of the S. offi-
cinalis group (P < 0.05), and also than D. stramonium extract. 
However, the parasite survival (PS) is a factor which better 
shows the effects of the extracts on amastigotes compared to IR, 
since it can represent the extent of infection. The PS values in 
the amastigote assay were 33%, 40%, and 42% for C. offici-
nalis (108.19 µg·mL1), D. stramonium (155.15 µg·mL1), and 
S. officinalis (184.32 µg·mL1), respectively (Table 2). The 
number of L. major amastigotes in macrophages treated with 
plant extracts were significantly lower (P < 0.001) than the  
negative control. There was no significant difference (P > 
0.05) between the number of L. major amastigotes in 
macrophages treated with different plant extracts (Fig. 2). 
Miltefosine, with more than 80% amastigote proliferation 
inhibitory activity (Table 2) and fifty-five amastigotes in 
one hundred macrophages (Fig. 2) had the best 
anti-amastigote activity among other groups. 
 
Fig. 1  The efficacy of methanolic plant extracts of macro-
phages infected with L. major amastigotes. ** P < 0.001 vs 
control group 









(108.19 µg·mL1)Control Groups 
20 ± 1.7* 42 ± 3*   40  ± 3.3*  33 ± 2.8* 96 ± 6.2 Parasite survival (PS) (%) 
22 ± 2** 8 ± 0.8 12 ± 1.4 10 ± 1.3 0 Toxicity for macrophage cell line (%) 
* P < 0.01 vs control group; ** P < 0.001 vs C. officinalis, D. stramonium, and S. officinalis groups 
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Fig. 2  Efficacy of methanolic plant extracts on the number 
of amastigotes in 100 macrophages. ** P < 0.001 vs control 
group 
 
Among the plant extracts, the flowers of C. officinalis had 
the best anti-leishmanial activity on both forms of leishmania. 
The other two plant extracts also had acceptable activity (IC50 
below 200 µg·mL1) against L. major promastigotes and amas-
tigotes. 
Cytotoxicity to macrophages  
The cytotoxicity of C. officinalis flowers, D. stramonium 
seeds and S. officinalis leaves methanolic extracts were de-
termined at IC50 concentration for each extract (Table 2). The 
cytotoxicity of these extracts were lower than (P < 0.001) that 
of miltefosine. The S. officinalis extract had the lowest toxicity 
against the macrophage cell line with only 8% toxicity at the IC50 
concentration (184.32 µg·mL1), whereas miltefosine had the 
highest toxicity (22%) at 5.3 µg·mL1 (Table 2). 
DMSO did not show any activity against L. major pro-
mastigotes and amastigotes (up to 1% in complete medium). 
Discussion  
Cutaneous leishmaniasis is one of the most common 
forms of the disease. It usually produces ulcers on the ex-
posed parts of the body. Although leishmaniasis is mostly 
self-healing without any treatment, it can cause serious de-
bilitating problems [1, 24]. The routine treatments for leishma-
niasis, pentavalent antimonial drugs, amphotericine B, and 
miltefosine, can cause serious side effects. Drug resistance 
has also become an important problem. Therefore, identifica-
tion and development of new medicinal agents is an urgent 
need for alternative treatment [7, 25]. On the other hand, most 
of the endemic areas are developing countries that have lim-
ited accessibility to effective drugs [3]. For this reason, it is 
necessary to discover endemic plants with anti-leishmanial 
activities; since plants can provide a valuable, safe, and inex-
pensive source of anti-microbial agents. Numerous studies 
from all over the world have been performed to recognize 
natural products with anti-leishmanial effects [26-28]. In the 
present study, methanolic extracts of C. officinalis flowers, D. 
stramonium seeds, and S. officinalis leaves showed consider-
able inhibitory effects against leishmania promastigotes with 
IC50 values below 0.2 mg·mL1, and against amastigotes with 
more than 60% lethality of parasite internalized to macro-
phages. Findings in this study indicate that methanolic ex-
tracts of C. officinalis flowers have high anti-leishmanial 
activity. However, the IC50 value of this extract against L. 
major promastigotes (108.19 µg·mL1) was much higher than 
that of miltefosine (5.3 µg·mL1), a well-known drug for 
leishmaniasis. The efficacy of the C. officinalis flowers ex-
tract on leishmaniasis is supported by the anti-amastigote 
activity of this extract on infected macrophages. The plant 
extract significantly reduced the number of amastigotes (88 
amastigotes in the sample wells, compared to 264 amastigotes 
in the negative control wells). 
The anti-promastigote and anti-amastigote activities of D. 
stramonium seeds and S. officinalis leaves were lower than 
that of the C. officinalis flower extract. However, both ex-
tracts reduced the infectivity of L. major amastigotes in 
macrophages, similar to C. officinalis. Although 
anti-leishmanial activities of these plant extracts are not 
comparable with the standard drug (miltefosine), but they 
show potential efficacy for treatment of leishmaniasis. There-
fore this could be a primary step in the preparation of natural 
drugs for cutaneous leishmaniasis. The plants used in this study 
are known to have antibacterial [11, 16, 18] and antifungal [12, 17, 19] 
properties, but there were no reports of antileishmanial activity. 
Some compounds known as antiparasitic [10], such as alkaloids, 
saponins, triterpenes, and flavonoids were found in these plant 
extracts [13, 29-31]. Therefore, it is likely that the anti-leishmanial 
activity of these plant extracts is performed by similar com-
pounds. However, further studies and fractionation of the 
plant extracts, are necessary to determine the components 
responsible for anti-leishmanial activity. 
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